Delcath Systems, Inc. (DCTH) saw its stock fall 5.35% to $11.33 after reporting preliminary third-quarter 2025 results and lowering full-year revenue guidance to $83-85 million due to seasonal trends and treatment center expansion timing. The stock opened at $11.76, reaching a high of $11.90 and a low of $11.18, with a previous close of $11.97. Trading on the NASDAQ, it had a volume of 0.29 million shares, above the average volume of 0.25 million. The 52-week range for the stock is $2.25 – $14.44.

Read more at Nasdaq: Delcath Stock Drops 5% After Preliminary Q3 Results And Full-Year Outlook Cut